New patent for Zogenix Inc drug FINTEPLA

Annual Drug Patent Expirations for FINTEPLA Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Zogenix Inc drug FINTEPLA appeared first on DrugPate…


Drug Patent Expirations for the Week of April 24, 2022

CERDELGA (eliglustat tartrate) Genzyme corp Patent: 7,253,185 Expiration: Apr 29, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]
The post Dru…


Biotechblog